Combining FAIMS based glycoproteomics and DIA proteomics reveals widespread proteome alterations in response to glycosylation occupancy changes in Neisseria gonorrhoeae
PROTEOMICS · 2024
DOI: 10.1002/pmic.202300496 ↗Kurz gefasst
Fachartikel in der Zeitschrift PROTEOMICS, 2024. Verfasst von Chris Hadjineophytou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences, Section for Genetics and Evolutionary Biology, University of Oslo, Oslo, Norway. Hauptthemen laut MEDLINE: Neisseria gonorrhoeae, Proteomics, Proteome, Bacterial Proteins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mizutani Foundation Glycoscience, Australian Research Council (ARC), National Health and Medical Research Council.
Abstract (Originalsprache)
Protein glycosylation is increasingly recognized as a common protein modification across bacterial species. Within the Neisseria genus O ‐linked protein glycosylation is conserved yet closely related Neisseria species express O‐ oligosaccharyltransferases (PglOs) with distinct targeting activities. Within this work, we explore the targeting capacity of different PglOs using Field Asymmetric Waveform Ion Mobility Spectrometry (FAIMS) fractionation and Data‐Independent Acquisition (DIA) to allow the characterization of the impact of changes in glycosylation on the proteome of Neisseria gonorrhoeae . We demonstrate FAIMS expands the known glycoproteome of wild type N. gonorrhoeae MS11 and enables differences in glycosylation to be assessed across strains expressing different pglO allelic chimeras with unique substrate targeting activities. Combining glycoproteomic insights with DIA proteomics, we demonstrate that alterations within pglO alleles have widespread impacts on the proteome of N. gonorrhoeae . Examination of peptides known to be targeted by glycosylation using DIA analysis supports alterations in glycosylation occupancy occurs independently of changes in protein levels and that the occupancy of glycosylation is generally low on most glycoproteins. This work thus expands our understanding of the N. gonorrhoeae glycoproteome and the roles that pglO allelic variation may play in governing genus‐level protein glycosylation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biosciences, Section for Genetics and Evolutionary Biology, University of Oslo, Oslo, Norway.
- Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Solna, Sweden.
- Clinical Microbiology, BioClinicum, Karolinska University Hospital, Solna, Sweden.
- Department of Biosciences, Centre for Ecological and Evolutionary Synthesis, University of Oslo, Oslo, Norway.
- Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
ORCID-Profile: Nichollas E Scott
Förderung
- Mizutani Foundation Glycoscience
- Australian Research Council (ARC)
- National Health and Medical Research Council
- Research Council of Norway
- Norges Forskningsråd
Zitieren
APA
Hadjineophytou, C., Loh, E., Koomey, M., & Scott, N. E. (2024). Combining FAIMS based glycoproteomics and DIA proteomics reveals widespread proteome alterations in response to glycosylation occupancy changes in Neisseria gonorrhoeae. PROTEOMICS. https://doi.org/10.1002/pmic.202300496
Vancouver
Hadjineophytou C, Loh E, Koomey M, Scott NE. Combining FAIMS based glycoproteomics and DIA proteomics reveals widespread proteome alterations in response to glycosylation occupancy changes in Neisseria gonorrhoeae. PROTEOMICS. 2024. doi:10.1002/pmic.202300496
BibTeX
@article{Hadjineophytou2024,
author = {Hadjineophytou, Chris and Loh, Edmund and Koomey, Michael and Scott, Nichollas E},
title = {Combining FAIMS based glycoproteomics and DIA proteomics reveals widespread proteome alterations in response to glycosylation occupancy changes in Neisseria gonorrhoeae},
journal = {PROTEOMICS},
year = {2024},
doi = {10.1002/pmic.202300496}
}
EUVIMED